| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-06 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-06 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-05 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-05 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-05 |